Boundary tissues, including the skin, are continually exposed to foreign antigens, which must be monitored and possibly eliminated. Upon exposure to foreign antigens, skin dendritic cells (DCs), including epidermal Langerhans cells (LCs), capture the antigens and migrate to draining lymph nodes (LNs), where the presentation of antigen to naive T cells occurs mainly in the T cell zone. In this location, the accumulation of naive T cells in the vicinity of DCs is mediated by signaling via the chemokine receptor CCR7 (ref. 1). The T cell zone in the draining LNs facilitates the efficient encounter of antigen-bearing DCs with antigen-specific naive T cells.
Boundary tissues, including the skin, are continually exposed to foreign antigens, which must be monitored and possibly eliminated. Upon exposure to foreign antigens, skin dendritic cells (DCs), including epidermal Langerhans cells (LCs), capture the antigens and migrate to draining lymph nodes (LNs), where the presentation of antigen to naive T cells occurs mainly in the T cell zone. In this location, the accumulation of naive T cells in the vicinity of DCs is mediated by signaling via the chemokine receptor CCR7 (ref. 1). The T cell zone in the draining LNs facilitates the efficient encounter of antigen-bearing DCs with antigen-specific naive T cells.
In contrast to T cells in LNs, the majority of T cells in the skin, including infiltrating skin T cells and skin-resident T cells, have an effector-memory phenotype 2 . In addition, the presentation of antigen to skin T cells by antigen-presenting cells (APCs) is the crucial step in the elicitation of acquired skin immune responses, such as contact dermatitis. Therefore, we investigated how antigen presentation occurs in the skin and if it is different from antigen presentation in LNs. Published studies using mouse contact hypersensitivity (CHS) as a model of human contact dermatitis have revealed that dermal DCs (dDCs) have a pivotal role in the transport and presentation of antigen to the LNs, but epidermal LCs do not 3 . In the skin, however, it remains unclear which subset of APCs presents antigens to skin T cells and how skin T cells efficiently encounter APCs. In addition, dermal macrophages are key modulators in CHS responses 4 , but the precise mechanisms by which macrophages are involved in the recognition of antigen in the skin have not yet been clarified. These unanswered questions prompted us to investigate where skin T cells recognize antigens and how skin T cells are activated in the elicitation phase of acquired cutaneous immune responses such as CHS.
When keratinocytes encounter foreign antigens, they immediately produce various proinflammatory mediators, such as interleukin 1 (IL-1) and tumor-necrosis factor, in an antigen-nonspecific manner 5, 6 . Proteins of the IL-1 family are considered important modulators in CHS responses because the activation of hapten-specific T cells is impaired in mice deficient in both IL-1α and IL-1β but not in mice deficient in tumor-necrosis factor 7 . IL-1α and IL-1β are agonistic ligands of the receptor for IL-1 (IL-1R). While IL-1α is stored in keratinocytes and is secreted upon exposure to nonspecific stimuli, IL-1β is produced mainly by epidermal LCs and dermal mast cells in an inflammasome-dependent manner via activation of the cytoplasmic pattern-recognition receptor NLRP3 and of caspase-1 and caspase-11. Because IL-1α and IL-1β are crucial in the initiation of acquired immune responses such as CHS, it is of great interest to understand how IL-1 modulates the recognition of antigen by skin T cells.
Using a mouse CHS model, here we examined how DCs and effector T cells encounter each other efficiently in the skin. We found that upon encountering antigenic stimuli, dDCs formed clusters in which effector T cells were activated and proliferated in an antigen-dependent manner. These DC-T cell clusters were initiated by skin macrophages via IL-1R signaling and were essential for the establishment of cutaneous acquired immune responses.
RESULTS

Formation of DC-T cell clusters at antigen-challenged sites
To explore the accumulation of cells of the immune system in the skin, we examined the clinical and histological features of the elicitation of human allergic contact dermatitis. Allergic contact dermatitis is the most common of eczematous skin diseases, affecting 15-20% of the general population worldwide 8 , and is mediated by T cells. Although antigens should be spread evenly over the surface of skin, clinical manifestations commonly include discretely distributed small vesicles (Fig. 1a) , which suggests an uneven occurrence of intense inflammation. Histological examination of allergic contact dermatitis showed spongiosis, intercellular edema in the epidermis and colocalization of perivascular infiltrates of CD3 + T cells and spotty accumulation of CD11c + DCs in the dermis, especially beneath the vesicles (Fig. 1b) . These findings led us to hypothesize that focal accumulation of T cells and DCs in the dermis might contribute to vesicle formation in early eczema.
To characterize the DC-T cell clusters in elicitation reactions, we used two-photon microscopy to obtain time-lapse images in a mouse model of CHS. We isolated T cells from the draining LNs of mice sensitized with the hapten DNFB (2,4-dinitrofluorobenzene), labeled the cells with fluorescent dye and transferred them into mice that express the common DC marker CD11c tagged with yellow fluorescent protein (YFP). In the steady state, YFP + dDCs distributed diffusely (Fig. 1c) , representative of nondirected movement in a random fashion (Supplementary Fig. 1 ), as reported before 9 . After topical challenge with DNFB, YFP + dDCs transiently increased their velocity and formed clusters in the dermis, with the clusters becoming larger and more evident after 24 h (Fig. 1c and Supplementary Movie 1) . At the same time, transferred T cells accumulated in the DC clusters and interacted with YFP + DCs for several hours ( Fig. 1d and Supplementary Movie 2) . Thus, we observed accumulation of DCs and T cells in the dermis in mice during CHS responses. We noted that the intercellular spaces between keratinocytes overlying the DC-T cell clusters in the dermis were enlarged (Fig. 1e) , which replicated observations made for human allergic contact dermatitis (Fig. 1b) .
We next sought to determine which of the two main DC populations in skin, epidermal LCs or dDCs, was essential for the elicitation of CHS. To deplete mice of all cutaneous DC subsets, we used mice with sequence expressing the diphtheria toxin receptor (DTR) under the control of the promoter of the gene encoding langerin as recipients (in such 'Langerin-DTR' mice, treatment with diphtheria toxin (DT) leads to depletion of langerin-positive cells) and mice that express a transgene encoding DTR under the control of promoter of the gene encoding CD11c as donors (in such 'CD11c-DTR' mice, treatment with DT leads to transient depletion of CD11c + DC populations). To selectively deplete mice of LCs or dDCs, we transferred bone marrow (BM) cells from C57BL/6 mice or CD11c-DTR mice into Langerin-DTR or C57BL/6 mice, respectively ( Supplementary Fig. 2a,b) . We injected DT into the chimeras to ensure depletion of each DC subset before elicitation and found that ear swelling and inflammatory histological findings were significantly attenuated in the absence of dDCs but not in the absence of LCs ( Fig. 1f and Supplementary Fig. 2c ). In addition, production of interferon-γ (IFN-γ) in skin T cells was substantially suppressed in mice depleted of dDCs (Fig. 1g) . These results suggested that dDCs, not epidermal LCs, were essential for T cell activation and the elicitation of CHS responses.
Antigen-dependent proliferation of skin effector T cells in situ
To evaluate the effect of DC-T cell clusters in the dermis, we determined whether T cells had acquired the ability to proliferate via the accumulation of DC-T cell clusters in the dermis. We purified CD4 + A r t i c l e s the cells with a division-tracking dye and transferred the cells into naive mice. Twenty-four hours after the application of DNFB to the recipient mice, we collected the skin to evaluate T cell proliferation by dilution of fluorescence intensity. Most of the infiltrating T cells (>90%) were CD44 + CD62L − effector T cells (Supplementary Fig. 2d ). Among the infiltrating T cells, CD8 + T cells proliferated actively, whereas the CD4 + T cells showed low proliferative potency (Fig. 2a) . This T cell proliferation was antigen dependent because T cells sensitized with the hapten TNCB (2,4,6-trinitrochlorobenzene) exhibited low proliferative activity in response to the application of DNFB (Fig. 2a) .
In line with that finding, the DC-T cell conjugation time was prolonged in the presence of the cognate antigen DNFB (Fig. 2b) , and the T cells interacting with DCs within DC-T cell clusters proliferated ( Fig. 2c and Supplementary Movie 3). These findings indicated that skin effector T cells conjugated with DCs and proliferated in situ in an antigen-dependent manner.
LFA-1-dependent activation of CD8 + T cells in DC-T cell clusters
Sustained interaction between DCs and naive T cells, known as the 'immunological synapse' , is maintained by cell adhesion molecules 10 .
In particular, the integrin LFA-1 (CD58) on T cells binds to cell-surface glycoproteins, such as the intercellular adhesion molecule ICAM-1, on APCs, which is essential for the proliferation and activation of naive T cells during antigen recognition in the LNs. To determine whether LFA-1-ICAM-1 interactions are required for the activation of effector T cells in DC-T cell clusters in the skin, we elicited a CHS response in mouse ear skin with DNFB, then injected KBA, a neutralizing antibody to LFA-1, intravenously 14 h later. Such administration of KBA reduced the accumulation of T cells in the dermis (Fig. 3a) . The velocity of T cells in the cluster was 0.65 ± 0.29 µm/min (mean ± s.d.) at 14 h after the DNFB challenge and increased up to threefold (1.64 ± 1.54 µm/min) at 8 h after treatment with KBA, while it was not affected by treatment with the isotype-matched control antibody immunoglobulin G (IgG) (Fig. 3b) . At the outside of clusters, T cells smoothly migrated at the mean velocity of 2.95 ± 1.19 µm/min, consistent with published results 11 , and this was not affected by treatment with the control antibody IgG (data not shown). Treatment with KBA also significantly attenuated ear swelling ( Fig. 3c ) as well as IFN-γ production by skin CD8 + T cells (Fig. 3d,e) . These results suggested that the DC-effector T cell conjugates were integrin dependent, similar to the DC-naive T cell interactions in draining LNs.
dDC clustering requires skin macrophages
We next examined the factors that initiated the accumulation of DC-T cell clusters. dDC clusters also formed in response to the initial application of hapten (sensitization phase), but their number decreased significantly 48 h after sensitization, while DC clusters persisted for 48 h in the elicitation phase ( Fig. 4a and Supplementary  Fig. 3a ). These DC clusters were abrogated 7 d after application of DNFB (data not shown). These observations suggested that the accumulation of DC-T cell clusters was initiated by DC clustering, which then induced the accumulation, proliferation and activation of T cells, a process that depended on the presence of antigen-specific effector T cells in situ. DC clusters were also induced by solvents (such as acetone) or adjuvants (such as dibutylphthalic acid) and by pathogenic inoculation with Mycobacterium bovis bacillus Calmette-Guérin ( Supplementary Fig. 3b,c) . In addition, we observed DC clusters not only in the ear skin but also in other regions, such as the back skin and the footpad (Supplementary Fig. 3d ). These results suggested that the formation of DC clusters was not an ear-specific event but was a general mechanism during skin inflammation. The abundance of DC clusters in response to the application of DNFB was not altered in mice that lack T cells and B cells (recombinase A r t i c l e s RAG-2-deficient mice), in mice deficient in lymphoid tissue-inducer cells (alymphoblastic (aly/aly) mice) 12 or in mice depleted of mast cells or basophils (Mas-TRECK or Bas-TRECK mice treated with DT) 13, 14 ( Fig. 4b) . In contrast, DC clustering was abrogated in C57BL/6 mice given transfer of BM from LysM-DTR mice (with sequence encoding a DTR cassette inserted into the gene encoding lysozyme M) followed by treatment of the recipients with DT to ensure depletion of both macrophages and neutrophils (Fig. 4b,c) . Depletion of neutrophils alone, by administration of antibody 1A8 to Ly6G, did not interfere with the formation of DC clusters (Fig. 4b) , which suggested that macrophages were required during the formation of DC clusters, but neutrophils were not. Of note, the formation of DC clusters was not attenuated by treatment with the LFA-1-neutralizing antibody KBA ( Supplementary  Fig. 3e,f) , which suggested that macrophage-DC interactions were LFA-1 independent. Consistent with the formation of DC clusters, elicitation of the CHS response (Fig. 4d) and IFN-γ production by skin T cells (Fig. 4e) were significantly suppressed in chimeras given LysM-DTR BM and treated with DT. Thus, skin macrophages were required for the formation of DC clusters, which was necessary for T cell activation and the elicitation of CHS.
Perivascular DCs clustering requires macrophages
To examine the migratory kinetics of dermal macrophages and DCs in vivo, we visualized them by two-photon microscopy. In vivo labeling of blood vessels with dextran conjugated to the hydrophobic red fluorescent dye TRITC (tetramethylrhodamine isothiocyanate) revealed that dDCs distributed diffusely in the steady state (Fig. 5a,  left) . After application of DNFB to the ears of mice previously sensitized with DNFB, dDCs accumulated mainly around post-capillary venules (Fig. 5a, right, and b) . Time-lapse imaging revealed that some dDCs showed directional migration toward TRITC + cells that were labeled red by incorporation of extravasated TRITC-dextran ( Fig. 5c and Supplementary Movie 4) . Most of the TRITC + cells were F4/80 + CD11b + macrophages (Supplementary Fig. 4a ). These observations prompted us to investigate the role of macrophages in DC accumulation. We used a chemotaxis assay to determine whether macrophages attracted the DCs. We isolated dDCs and dermal macrophages from dermal skin cell suspensions and incubated them for 12 h in a Transwell assay. dDCs placed in the upper wells migrated efficiently to lower wells that contained dermal macrophages (Fig. 5d) . However, we did not observe such dDC migration when macrophages were absent from the lower wells (Fig. 5d) . Thus, dermal macrophages were able to attract dDCs in vitro, which may have led to the accumulation of dDCs around post-capillary venules.
DC cluster formation requires IL-1a upon antigen challenge
We attempted to explore the mechanism underlying the formation of DC clusters. We observed that DC accumulation occurred during the first application of hapten (Fig. 4a) , which suggested that an antigen-nonspecific mechanism, such as production of the proinflammatory mediator IL-1, may initiate DC clustering. DNFB-induced accumulation of DCs was not suppressed in mice deficient in NLRP3 or deficient in caspase-1 and caspase-11 more than their wild-type counterparts, but it was significantly lower in IL-1R1-deficient mice (which lack the receptor for IL-1α and IL-1β and for the IL-1 receptor antagonist (IL-1ra)) than in their wild-type counterparts, as well as after the subcutaneous administration of IL-1ra than before treatment with the antagonist (Fig. 6a,b) . Consistent with those observations, the elicitation of CHS and IFN-γ production by skin T cells were significantly attenuated in mice that lacked both IL-1α and IL-1β (Fig. 6c,d) . In addition, the formation of dDC clusters was suppressed significantly by the subcutaneous injection of a neutralizing antibody to IL-1α but A r t i c l e s was suppressed only marginally by a neutralizing antibody to IL-1β (Fig. 6b) . Because keratinocytes are known to produce IL-1α upon application of a hapten 15 , our results suggested a major role for IL-1α in mediating the formation of DC clustering.
M2 macrophages produce chemokine CXCL2 to attract dDCs
To further characterize how macrophages attract dDCs, we examined expression of the gene encoding IL-1Rα (Il1r1) in BM-derived classically activated (M1) and alternatively activated (M2) macrophages, classified as such on the basis of differences in the expression of Tnf, Nos2, Il12a, Arg1, Retnla and Chi313 mRNA 16 (Supplementary Fig. 4b ). We found that M2 macrophages had higher expression of Il1r1 mRNA than did M1 macrophages (Fig. 6e) . We also found that subcutaneous injection of pertussis toxin, an inhibitor specific for inhibitory regulative G protein, almost completely abrogated the formation of DC clusters in response to hapten stimuli (Fig. 6b) , which suggested that signaling through chemokines coupled to the inhibitory regulative G protein was required for the formation of DC clusters.
We next used microarray analysis to examine the effect of IL-1α on the expression of chemokine-encoding genes in M1 and M2 macrophages. Treatment with IL-1α did not enhance such expression in M1 macrophages, whereas it increased the expression of Ccl5, Ccl17, Ccl22 and Cxcl2 mRNA in M2 macrophages (Supplementary Table 1 ). Among those, Cxcl2 mRNA expression was enhanced most prominently by treatment with IL-1α, a result we confirmed by real-time PCR analysis (Fig. 6f) . Consistently, Cxcl2 mRNA expression was much higher in DNFB-painted skin than in untreated skin (Supplementary Fig. 5a ) and was not affected by neutrophil depletion with the 1A8 antibody to Ly6G (Supplementary Fig. 5b,c) . In addition, IL-1α-treated dermal macrophages produced Cxcl2 mRNA in vitro (Supplementary Fig. 5d ). These results suggested that dermal macrophages, but not neutrophils, were the main source of CXCL2 during CHS. We also detected high expression of Cxcr2 mRNA (which encodes the receptor for CXCL2) in DCs ( Supplementary Fig. 5e) ; this prompted us to examine the role of CXCR2 in dDCs. The formation of DC clusters in response to DNFB was substantially reduced by intraperitoneal administration of the CXCR2 inhibitor SB265610 (ref. 17) (Fig. 6g) . In addition, treatment with SB265610 during the elicitation of CHS with DNFB inhibited ear swelling (Fig. 6h) and IFN-γ production by skin T cells (Fig. 6i) .
Together our results indicated that in the absence of effector T cells specific for a cognate antigen (i.e., in the sensitization phase of CHS), DC clustering was a transient event, and hapten-carrying DCs migrated into draining LNs to establish sensitization. On the other hand, in the presence of the antigen and antigen-specific effector or memory T cells, DC clustering was followed by accumulation of T cells (i.e., in the elicitation phase of CHS) (Supplementary Fig. 6 ). Thus, dermal macrophages were essential for initiating the formation of DC clusters through the production of CXCL2, and DC clustering had a role in the efficient activation of skin T cells.
DISCUSSION
Although the mechanistic events in the sensitization phase in cutaneous immunity have been studied thoroughly over 20 years 18, 19 , the types of immunological events that occur during the elicitation phases in the skin has remained unclear. Here we have described the antigen-dependent induction of DC-T cell clusters in the skin in a mouse model of CHS and showed that DC-effector T cell interactions in these clusters were required for the induction of efficient antigenspecific immune responses in the skin. We found that dDCs, but not epidermal LCs, were essential for the presentation of antigen to skin effector T cells and that they exhibited sustained association with effector T cells in an antigen-and LFA-1-dependent manner. IL-1α, not the inflammasome, initiated the formation of these perivascular DC clusters.
Epidermal contact with antigens triggers the release of IL-1 in the skin 15 . Published studies have shown that the epidermal keratinocytes constitute a major reservoir of IL-1α 6 and that mechanical stress applied to keratinocytes permits the release of large amounts of IL-1α even in the absence of cell death 20 . The cellular source of IL-1α in this process remains unclear. We found that IL-1α activated macrophages that subsequently attracted dDCs, mainly to areas around post-capillary venules, where effector T cells are known to transmigrate from the blood into the skin 21 . In the presence of the antigen and antigen-specific npg effector T cells, DC clustering was followed by T cell accumulation. Therefore, we propose that these perivascular dDC clusters may provide antigen-presentation sites for efficient activation of effector T cells. This is suggested by the observations that CHS responses and intracutaneous T cell activation were attenuated substantially in the absence of these clusters, in conditions of macrophage depletion or inhibition of integrin function, IL-1R signaling 22, 23 or CXCR2 signaling 24 .
In contrast to antigen presentation in the skin, antigen presentation in other peripheral barrier tissues is relatively well understood. In submucosal areas, specific sentinel lymphoid structures (mucosa-associated lymphoid tissue (MALT)) serve as peripheral antigen-presentation sites 25 , and lymphoid follicles are present in non-inflammatory bronchi (bronchus-associated lymphoid tissue (BALT)). These structures serve as antigen-presentation sites in nonlymphoid peripheral organs. By analogy, the concept of skin-associated lymphoid tissue (SALT) was proposed in the early 1980s, on the basis of findings that cells in the skin are able to capture, process and present antigens 26, 27 . However, the role of cellular skin components as antigen-presentation sites has remained uncertain. Here we have identified an inducible structure formed by dermal macrophages, dDCs and effector T cells, which seemed to accumulate sequentially. Because formation of this structure was essential for efficient activation of effector T cells, these inducible leukocyte clusters may function as SALTs. Unlike leukocyte clusters in MALT, these leukocyte clusters were not found in the steady state but were induced during the development of an adaptive immune response. Therefore, these clusters might be better called 'inducible SALTs' , similar to inducible BALTs in the lung 28 . In contrast to the cells present in inducible BALT, we did not identify naive T cells or B cells in SALT (data not shown), which suggested that the leukocyte clusters in the skin may be specialized for the activation of effector T cells but not for the activation of naive T cells. Our findings suggest that approaches for the selective inhibition of this structure may have novel therapeutic benefit in inflammatory disorders of the skin.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. GEO: microarray data, GSE53680. 
ONLINE METHODS
Mice. 8-to 12-week-old female C57BL/6 mice were used in this study. C57BL/6N mice were from SLC. Langerin-eGFP-DTR mice 29 , CD11c-DTR mice 30 , CD11c-YFP mice (that express CD11c tagged with YFP) 31 , LysM-DTR mice 32 , RAG-2-deficient mice 33 , Mas-TRECK mice 13, 14 , Bas-TRECK mice 13, 14 , ALY/NscJcl-aly/aly mice 12 , IL-1α/β-deficient mice 34 , IL-1R1-deficient mice 35 , NLRP3-deficient mice 36 and caspase-1/11-deficient mice 37 have been described. All experimental procedures were approved by the Institutional Animal Care and Use Committee of Kyoto University Graduate School of Medicine.
Human subjects. Biopsy samples of human skin were obtained from a nickelreactive patch after 48 h after placement of nickel patch tests in patients with previously proven allergic contact dermatitis. A biopsy of petrolatum-occluded skin was also obtained as a control. Depletion of cutaneous DC subsets, macrophages and neutrophils. For depletion of all cutaneous DC subsets (including LCs), 6-week-old Langerin-DTR mice were irradiated (two doses of 550 rads given 3 h apart) and were given transfer of 1 × 10 7 BM cells from CD11c-DTR mice. Eight weeks later, 2 µg DT (Sigma-Aldrich) was injected intraperitoneally. For selective depletion of LCs, irradiated Langerin-DTR mice were given transfer of BM cells from C57BL/6 mice, and 1 µg DT was injected. For selective depletion of dDCs, irradiated C57BL/6 mice were given transfer of BM cells from CD11c-DTR mice, and 2 µg DT was injected. For depletion of macrophages, irradiated C57BL/6 mice were given transfer of BM cells from LysM-DTR mice and 800 ng DT was injected. For depletion of neutrophils, anti-Ly6G (1A8; BioXCell) was administered to mice intravenously at a dose of 0.5 mg per mouse 24 h before experiments.
Time-lapse imaging of cutaneous DCs, macrophages and T cells. Cutaneous DCs were observed in CD11c-YFP mice. For labeling of cutaneous macrophages in vivo, 5 mg TRITC-dextran (Sigma-Aldrich) was injected intravenously and mice were allowed to 'rest' for 24 h. At that time, cutaneous macrophages became fluorescent because they had incorporated extravasated dextran. For labeling of skin-infiltrating T cells, T cells from DNFB-sensitized mice were labeled with CellTracker Orange (CMTMR (5-(and-6)-(((4-chloromethyl)benzoyl) amino)tetramethylrhodamine); Invitrogen) and were adoptively transferred into recipient mice. Keratinocytes and sebaceous glands were visualized by subcutaneous injection of isolectin B4 (Invitrogen) and BODIPY (Molecular Probes), respectively. Mice were positioned on a heating plate on the stage of a two-photon IX-81 microscope (Olympus) and their ear lobes were fixed beneath a cover slip with a single drop of immersion oil. Stacks of ten images, spaced 3 µm apart, were acquired at intervals of 1-7 min for up to 24 h. For calculation of T cell and DC velocities, movies were processed and analyzed with Imaris 7.2.1 software (Bitplane).
Histology and immunohistochemistry.
For histological examination, tissues were fixed with 10% formalin in phosphate-buffered saline, then were embedded in paraffin. Sections with a thickness of 5 µm were prepared and then were stained with hematoxylin and eosin. For whole-mount staining, the ears were split into dorsal and ventral halves and were incubated for 30 min at 37 °C with 0.5 M ammonium thiocyanate. Then the dermal sheets were separated and fixed in acetone for 10 min at −20 °C. After treatment with Image-iT FX Signal Enhancer (Invitrogen), the sheets were incubated with antibody to mouse MHC class II (M5/114.15.2; eBioscience) followed by incubation with antibody to rat IgG conjugated to Alexa Fluor 488 (A-11006; Invitrogen) or Alexa Fluor 594 (A-11007; Invitrogen). The slides were mounted with a ProLong Antifade kit with the DNA-binding dye DAPI (4′6-diamidino-2-phenylindole; Molecular Probes) and were observed with a fluorescent microscope (BZ-900; KEYENCE). The number and size of DC clusters were evaluated in ten fields of 1 mm 2 per ear and were assigned scores according to the criteria in Supplementary Figure 5a .
Cell isolation and flow cytometry. For the isolation of skin lymphocytes, the split ears were incubated for 1 h at 37 °C in digestion buffer (RPMI medium supplemented with 2% FCS, 0.33 mg/ml of Liberase TL (Roche) and 0.05% DNase I (Sigma-Aldrich)). After that incubation, the tissues were disrupted by passage through a 70-µm cell strainer and stained with the appropriate antibodies (identified below). For analysis of intracellular cytokine production, cell suspensions were obtained in the presence of 10 µg/ml of brefeldin A (Sigma-Aldrich) and were fixed with Cytofix Buffer and permeabilized with Perm/Wash Buffer according to the manufacturer's protocol (BD Biosciences). Cells were stained with the following: antibody to mouse CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD11b (M1/70), anti-CD11c (N418), anti-B220 (RA3-6B2), antibody to MHC class II (M5/114.15.2), anti-F4/80 (BM8), anti-IFN-γ (XMG1.2), anti-Gr1 (RB6-8c5) and 7-amino-actinomycin D (all from eBioscience); anti-mouse CD45 (30-F11) and anti-TCR-β (H57-597; both from BioLegend); and anti-CD16-CD32 (2.4G2; BD Biosciences). Flow cytometry was done with an LSR Fortessa (BD Biosciences) and data were analyzed with FlowJo software (TreeStarA).
Chemotaxis assays. Chemotaxis was assessed as described with some modifications 38 . The dermis of the ear skin was minced and then was digested for 30 min at 37 °C with 2 mg/ml collagenase type II (Worthington Biochemical) containing 1 mg/ml hyaluronidase (Sigma-Aldrich) and 100 µg/ml DNase I (Sigma-Aldrich). DDCs and macrophages were isolated with an autoMACS. Alternatively, BM-derived DCs and macrophages were prepared. 1 × 10 6 DCs were added to a Transwell insert with a pore size of 5 µm (Corning), and 5 × 10 5 macrophages were added to the lower wells, and the cells were incubated for 12 h at 37 °C. A known number of fluorescent reference beads (FlowCount fluorospheres; Beckman Coulter) were added to each sample to allow accurate quantification of cells that had migrated to the lower wells by flow cytometry.
Cell proliferation assay. Mice were sensitized with 25 µl 0.5% DNFB or 7% trinitrochlorobenzene (Chemical Industry). Five days later, T cells were magnetically separated from the draining LNs of each group of mice and were labeled with CellTrace Violet according to the manufacturer's protocol (Invitrogen). 1 × 10 6 T cells were adoptively transferred into naive mice, and the ears of the recipient mice were challenged with 20 µl of 0.5% DNFB. 24 h later, ears were collected and analyzed by flow cytometry.
In vitro differentiation of DCs and M1 and M2 macrophages from BM cells. BM cells from the tibias and fibulas were plated at a density of 5 × 10 6 cells per 10-cm dish on day 0. For DC differentiation, cells were cultured at 37 °C in 5% CO 2 in cRPMI medium (RPMI medium supplemented with 1% l-glutamine, 1% HEPES, 0.1% 2-mercaptoethanol and 10% FBS) containing 10 ng/ml granulocyte-macrophage colony-stimulating factor (Peprotech). For macrophage differentiation, BM cells were cultured in cRPMI medium containing 10 ng/ml macrophage colony-stimulating factor (Peprotech). The medium was replaced on days 3 and 6 and cells were harvested on day 9. For the induction of M1 macrophages or M2 macrophages, cells were stimulated for 48 h with IFN-γ (10 ng/ml; R&D Systems) or with IL-4 (20 ng/ml; R&D Systems), respectively.
In vitro IL-1a-stimulation assay of dermal macrophages. Dermal macrophages were separated from mice deficient in IL-1α and IL-1β 34 to avoid preactivation during cell preparations. Split ears were treated for 30 min at 37 °C with 0.25% trypsin and EDTA for removal of the epidermis, then were minced and then incubated with collagenase as described above. CD11b + cells were separated by magnetic-activated cell sorting, and 2 × 10 5 cells per well in 96-well plates were incubated for 24 h with or without 10 ng/ml IL-1α (R&D Systems). 
